Jan 28 (Reuters) - Shares of private equity firm Carlyle Group Inc-backed Ortho Clinical Diagnostics fell 8.8% in their Nasdaq debut on Thursday, giving the Raritan, New Jersey-based diagnostics company a market capitalization of $3.36 billion.
Reporting by Amruta Khandekar in Bengaluru; Editing by Vinay Dwivedi
我们的标准: 汤森路透“信任原则”